Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Walz, Juliane
BeliVeR, NCT05069051: Belimumab in Patients with Chronic Lymphocytic Leukemia	Active, not recruiting	2	120	Europe	Belimumab 200 MG/ML [Benlysta], standard of care	University Hospital Tuebingen, GlaxoSmithKline	Chronic Lymphoid Leukemia in Relapse	07/26	07/27